Literature DB >> 24589755

[Bilateral diffuse uveal melanocytic proliferation in a patient with metastatic breast cancer].

A E Höh1, F G Holz, S Dithmar.   

Abstract

A 64-year-old female patient with a history of metastatic breast cancer presented with bilateral deterioration of visual acuity over a period of several weeks. Examination revealed patchy fundus pigmentation, serous retinal detachment and cataract in both eyes. After diagnosis of a bilateral diffuse uveal melanocytic proliferation (BDUMP) and due to disease progression, a course of plasmapheresis three times a week over a period of 2 weeks was initiated. Apart from the occurrence of peripheral edemas the therapy was well-tolerated by the patient. Treatment success could not be evaluated because the patient died a short time later. This is the first reported case of BDUMP due to breast cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24589755     DOI: 10.1007/s00347-014-3019-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  12 in total

1.  Bilateral diffuse uveal melanocytic proliferation simulating an arteriovenous fistula.

Authors:  M A Murphy; W M Hart; R J Olk
Journal:  J Neuroophthalmol       Date:  1997-09       Impact factor: 3.042

2.  High-resolution OCT imaging of RPE degeneration in bilateral diffuse uveal melanocytic proliferation.

Authors:  Cagri G Besirli; Grant M Comer
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010 Nov-Dec

Review 3.  The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases.

Authors:  Elizabeth A Jaben; Jose S Pulido; Sean Pittock; Svetomir Markovic; Jeffrey L Winters
Journal:  J Clin Apher       Date:  2011-09-05       Impact factor: 2.821

4.  Ocular paraneoplastic syndrome: a case of bilateral diffuse uveal melanocytic proliferation.

Authors:  Efrem Mandelcorn; Kwesi McGuire; William Dixon; Mark Mandelcorn
Journal:  Retina       Date:  2009-10       Impact factor: 4.256

5.  Incidence and clinical characteristics of symptomatic choroidal metastasis from breast cancer.

Authors:  Klaus-Martin Kreusel; Nikolaos E Bechrakis; Lothar Krause; Thomas Wiegel; Michael H Foerster
Journal:  Acta Ophthalmol Scand       Date:  2007-05

Review 6.  Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management.

Authors:  Ehsan Rahimy; David Sarraf
Journal:  Surv Ophthalmol       Date:  2013 Sep-Oct       Impact factor: 6.048

7.  Bilateral melanocytic uveal tumors associated with systemic non-ocular malignancy. Malignant melanomas or benign paraneoplastic syndrome?

Authors:  C E Margo; P R Pavan; D Gendelman; E Gragoudas
Journal:  Retina       Date:  1987       Impact factor: 4.256

Review 8.  Bilateral diffuse uveal melanocytic proliferation associated with pancreatic carcinoma: a case report and literature review of this paraneoplastic syndrome.

Authors:  Kevin D O'Neal; Kelly J Butnor; Kathryn R Perkinson; Alan D Proia
Journal:  Surv Ophthalmol       Date:  2003 Nov-Dec       Impact factor: 6.048

9.  Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma.

Authors:  J D Gass; R G Gieser; C P Wilkinson; D E Beahm; S E Pautler
Journal:  Arch Ophthalmol       Date:  1990-04

10.  A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes.

Authors:  Sarah L Miles; Richard M Niles; Sean Pittock; Richard Vile; John Davies; Jeffrey L Winters; Nakhleh E Abu-Yaghi; Axel Grothey; Mustaqeem Siddiqui; Judith Kaur; Lynn Hartmann; Kimberly R Kalli; Larry Pease; Daniel Kravitz; Svetomir Markovic; Jose S Pulido
Journal:  Retina       Date:  2012-10       Impact factor: 4.256

View more
  1 in total

1.  Bilateral Diffuse Uveal Melanocytic Proliferation in a Woman with Metastatic Scalp Squamous Cell Carcinoma Treated with Cemiplimab.

Authors:  Etti Katzburg; Dinah Zur; Orit Gutfeld; Ilya Kirgner; Zohar Habot-Wilner
Journal:  Case Rep Ophthalmol       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.